Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Si Huan
Beijing, Beijing, China
- Ownership
- Private
- Employees
- ~3500
- Development stage
- Other
01
Overview
Sihuan Pharmaceutical Holdings Group Ltd. is a leading Chinese pharmaceutical company with a diversified portfolio spanning cardio-cerebral vascular (CCV) drugs, oncology, diabetes, and medical aesthetics. Founded in 2001, the company has evolved from a CCV specialist into a modern conglomerate with robust R&D platforms like Xuanzhu Biopharmaceutical and Huisheng Biopharmaceutical. It is particularly well-known for its dominant position in the Chinese medical aesthetics market, being the exclusive distributor of Letybo (botulinum toxin). The company also operates a CDMO business and maintains a significant pipeline of innovative small molecules and biologics. Sihuan is listed on the Hong Kong Stock Exchange and continues to expand its footprint in high-growth therapeutic areas.
- Therapeutic areas
- CardiovascularNeurologyEndocrinologyDermatologyGastroenterologyInfectious DiseasesOncology
- Modalities
- Small moleculeMonoclonal antibodyRecombinant proteinPeptidesBiologic
- Industry
- Biotech
02
Partnerships
Beyond the preview
Go deeper on Beijing Si Huan.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Si Huan.